Trials / Completed
CompletedNCT03674476
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986036 in Participants With Varying Degrees of Renal Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This is an investigational study to evaluate the experimental medication BMS-986036 in participants with different levels of kidney function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986036 | Specified dose on specified days |
Timeline
- Start date
- 2018-09-11
- Primary completion
- 2019-06-24
- Completion
- 2019-06-24
- First posted
- 2018-09-17
- Last updated
- 2019-10-08
Locations
4 sites across 2 countries: Czechia, Hungary
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03674476. Inclusion in this directory is not an endorsement.